![Frontiers | The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity Frontiers | The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity](https://www.frontiersin.org/files/Articles/553715/fimmu-11-553715-HTML/image_m/fimmu-11-553715-g001.jpg)
Frontiers | The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity
M9657, a novel tumor-targeted conditional anti-CD137 agonist displays MSLN-dependent anti-tumor immunity
![A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade | Nature Communications A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade | Nature Communications](https://media.springernature.com/m685/springer-static/image/art%3A10.1038%2Fs41467-021-24767-5/MediaObjects/41467_2021_24767_Fig7_HTML.png)
A human CD137×PD-L1 bispecific antibody promotes anti-tumor immunity via context-dependent T cell costimulation and checkpoint blockade | Nature Communications
![Early signal transduction events from CD137. Schematic representation... | Download Scientific Diagram Early signal transduction events from CD137. Schematic representation... | Download Scientific Diagram](https://www.researchgate.net/publication/235787754/figure/fig1/AS:393380174549004@1470800550903/Early-signal-transduction-events-from-CD137-Schematic-representation-of-TRAF2-and-TRAF1.png)
Early signal transduction events from CD137. Schematic representation... | Download Scientific Diagram
![PDF] CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development | Semantic Scholar PDF] CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/9b38f2f0bf049aa78ec4687809f0b3029dda16b7/2-Figure1-1.png)
PDF] CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development | Semantic Scholar
![Cancers | Free Full-Text | CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development Cancers | Free Full-Text | CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development](https://pub.mdpi-res.com/cancers/cancers-13-02288/article_deploy/html/images/cancers-13-02288-ag.png?1620833603)
Cancers | Free Full-Text | CD137 as an Attractive T Cell Co-Stimulatory Target in the TNFRSF for Immuno-Oncology Drug Development
![Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy - Sanchez‐Paulete - 2016 - European Journal of Immunology - Wiley Online Library Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy - Sanchez‐Paulete - 2016 - European Journal of Immunology - Wiley Online Library](https://onlinelibrary.wiley.com/cms/asset/37680807-c4ec-4632-b4ed-5ca22fd72fe2/eji3559-gra-0001-m.jpg?trick=1707522155406)
Deciphering CD137 (4‐1BB) signaling in T‐cell costimulation for translation into successful cancer immunotherapy - Sanchez‐Paulete - 2016 - European Journal of Immunology - Wiley Online Library
![Frontiers | The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity Frontiers | The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity](https://www.frontiersin.org/files/Articles/553715/fimmu-11-553715-HTML/image_m/fimmu-11-553715-g007.jpg)
Frontiers | The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity
![CD137 (4-1BB) Monoclonal Antibody (4B4 (4B4-1)), APC-eFluor™ 780, eBioscience™, Invitrogen™: Anticorps primaires Antibodies | Fisher Scientific CD137 (4-1BB) Monoclonal Antibody (4B4 (4B4-1)), APC-eFluor™ 780, eBioscience™, Invitrogen™: Anticorps primaires Antibodies | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/LSG/antibodies/47-1379-cd137-flow-cytometry-06jan2020lsrf2drz-4b4-apc-efluor780-abmaint_20200107132423.jpg-650.jpg)
CD137 (4-1BB) Monoclonal Antibody (4B4 (4B4-1)), APC-eFluor™ 780, eBioscience™, Invitrogen™: Anticorps primaires Antibodies | Fisher Scientific
![Cells | Free Full-Text | The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus Cells | Free Full-Text | The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus](https://www.mdpi.com/cells/cells-08-01044/article_deploy/html/images/cells-08-01044-g001.png)
Cells | Free Full-Text | The Progress of Investigating the CD137-CD137L Axis as a Potential Target for Systemic Lupus Erythematosus
![The effects of inhibition of CD137-CD137L interaction by antagonistic... | Download Scientific Diagram The effects of inhibition of CD137-CD137L interaction by antagonistic... | Download Scientific Diagram](https://www.researchgate.net/publication/283812273/figure/fig3/AS:667926185127942@1536257420473/The-effects-of-inhibition-of-CD137-CD137L-interaction-by-antagonistic-anti-CD137-or.png)
The effects of inhibition of CD137-CD137L interaction by antagonistic... | Download Scientific Diagram
![The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity. - Abstract - Europe PMC The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity. - Abstract - Europe PMC](https://europepmc.org/articles/PMC7758191/bin/fimmu-11-553715-g006.jpg)
The Murine CD137/CD137 Ligand Signalosome: A Signal Platform Generating Signal Complexity. - Abstract - Europe PMC
![CD137 Ligand (4-1BB Ligand) Monoclonal Antibody (4H3), APC, eBioscience™, Invitrogen™ 100 Tests; APC CD137 Ligand (4-1BB Ligand) Monoclonal Antibody (4H3), APC, eBioscience™, Invitrogen™ | Fisher Scientific CD137 Ligand (4-1BB Ligand) Monoclonal Antibody (4H3), APC, eBioscience™, Invitrogen™ 100 Tests; APC CD137 Ligand (4-1BB Ligand) Monoclonal Antibody (4H3), APC, eBioscience™, Invitrogen™ | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/LSG/figures/17-5906-42-CD137L-041417LSRFND-flow-cytometry-cd19-APC_20170414143905.jpg-650.jpg)
CD137 Ligand (4-1BB Ligand) Monoclonal Antibody (4H3), APC, eBioscience™, Invitrogen™ 100 Tests; APC CD137 Ligand (4-1BB Ligand) Monoclonal Antibody (4H3), APC, eBioscience™, Invitrogen™ | Fisher Scientific
![CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8+ T cells via NF-κB signaling | Cancer Cell International | Full Text CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8+ T cells via NF-κB signaling | Cancer Cell International | Full Text](https://media.springernature.com/m685/springer-static/image/art%3A10.1186%2Fs12935-020-01605-0/MediaObjects/12935_2020_1605_Fig7_HTML.png)
CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8+ T cells via NF-κB signaling | Cancer Cell International | Full Text
![Contributions of Costimulatory Molecule CD137 in Endothelial Cells | Journal of the American Heart Association Contributions of Costimulatory Molecule CD137 in Endothelial Cells | Journal of the American Heart Association](https://www.ahajournals.org/cms/asset/e2d1eb4f-d0ba-46ab-9a32-d7adb9e4e4c4/jah36275-fig-0001.png)
Contributions of Costimulatory Molecule CD137 in Endothelial Cells | Journal of the American Heart Association
![CD137 (4-1BB) Monoclonal Antibody (17B5), PE-Cyanine7, eBioscience™, Invitrogen™ 25 μg; PE-Cyanine7 Primary Antibodies CD101 to CD150 | Fisher Scientific CD137 (4-1BB) Monoclonal Antibody (17B5), PE-Cyanine7, eBioscience™, Invitrogen™ 25 μg; PE-Cyanine7 Primary Antibodies CD101 to CD150 | Fisher Scientific](https://assets.fishersci.com/TFS-Assets/LSG/figures/25-1371-82_CD137-4-1BB_Flow_1-20170119083539.jpg-650.jpg)
CD137 (4-1BB) Monoclonal Antibody (17B5), PE-Cyanine7, eBioscience™, Invitrogen™ 25 μg; PE-Cyanine7 Primary Antibodies CD101 to CD150 | Fisher Scientific
![CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation | Nature Communications CD137 (4-1BB) costimulation of CD8+ T cells is more potent when provided in cis than in trans with respect to CD3-TCR stimulation | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-021-27613-w/MediaObjects/41467_2021_27613_Fig1_HTML.png)